• (418) 380-0552
La Clinique de la Tête
  • Accueil
  • SERViCES
    • Céphalées
    • Mâchoire
    • Cervicalgie
  • Corpus
    • 1. Introduction
    • 2. Généralités
      • 2.1 Histoire
      • 2.2 Classification
      • 2.3 Épidémiologie
      • 2.4 Évaluation subjective
      • 2.5 Évaluation neurologique
      • 2.6 Évaluation vasculaire
      • 2.7 Étourdissements
      • 2.8 Formulaires
    • 3. Céphalée cervicogénique
      • 3.1 Description
        • 3.1.1 Classification
        • 3.1.2 Épidémiologie
        • 3.1.3 Pathophysiologie
        • 3.1.4 Facteurs contributifs
        • 3.1.5 Étourdissements cervicogéniques
        • 3.1.6 Références
      • 3.2 Évaluation
      • 3.3 Traitement
    • 4. Céphalée de tension
      • 4.1 Description
        • 4.1.1 Classification
        • 4.1.2 Épidémiologie
        • 4.1.3 Pathophysiologie
        • 4.1.4 Facteurs contributifs
        • 4.1.5 Diagnostic différentiel
        • 4.1.6 Références
      • 4.2 Évaluation
      • 4.3 Traitement
    • 5. Migraine
      • 5.1 Description
        • 5.1.1 Classification
        • 5.1.2 Les phases d’une crise
        • 5.1.3 Facteurs déclenchants
        • 5.1.4 Épidémiologie
        • 5.1.5 Pathophysiologie
        • 5.1.6 Composante génétique
        • 5.1.7 Composante pharmacologique
        • 5.1.8 Théorie du continuum
        • 5.1.9 Intérêt de la physiothérapie
        • 5.1.10 Conclusion
        • 5.1.11 Références
      • 5.2 Évaluation
      • 5.3 Traitement
      • 5.4 Particularités chez les femmes
      • 5.5 Particularités chez les enfants
    • 6. Céphalées trigémino-autonomiques
    • 7. Dysfonction temporo-mandibulaire
    • 8. Autres désordres
      • 8.5 Troubles du sommeil
        • 8.5.1 Le syndrome d’apnées du sommeil
        • 8.5.2 Autres troubles du sommeil
        • 8.5.3 Liens entre sommeil et douleur
        • 8.5.4 Liens entre sommeil et céphalées
        • 8.5.5 Réféfences
      • 8.7 Céphalée post-COVID
  • Blogue
    • DiVERS DOULEUR PATHOLOGiES RECHERCHE SANTÉ THÉRAPiES
      DiVERS

      Migraine World Summit 2020

      12 mars 2020

      DiVERS

      « Skull-Breaker Challenge » le défi TikTok hyper dangereux

      11 mars 2020

      DiVERS

      L’intelligence artificielle découvre un nouvel antibiotique

      27 février 2020

      DiVERS

      La position de la langue influence le développement…

      29 mai 2019

      DOULEUR

      Douleur et hyperventilation

      19 novembre 2022

      DOULEUR

      L’impact de la posture de sommeil et des…

      30 août 2021

      DOULEUR

      Nutrition et douleurs chroniques

      29 juillet 2020

      DOULEUR

      Radiculopathie cervicale ou traitement de canal ?

      27 avril 2020

      PATHOLOGiES

      Quel est le lien entre le CGRP et…

      17 octobre 2021

      PATHOLOGiES

      Pourquoi l’implication de la posture serait plus prévalente…

      18 février 2021

      PATHOLOGiES

      Tests pour étourdissements cervicogéniques

      18 octobre 2020

      PATHOLOGiES

      La céphalée attribuable à la tension artérielle

      30 juillet 2020

      RECHERCHE

      Le niveau de douleur adulte dicté par les…

      26 avril 2020

      RECHERCHE

      Dysfonction musculaire chez les migraineux

      24 décembre 2015

      RECHERCHE

      Quelles sont les tendances dans le monde des…

      9 mars 2015

      RECHERCHE

      Un lien entre migraine et coliques ?

      15 octobre 2014

      SANTÉ

      Le curcuma comme anti-inflammatoire ?

      28 février 2016

      SANTÉ

      Le sucre rend-t-il votre enfant hyperactif ?

      25 mars 2015

      SANTÉ

      Êtes-vous couche-tôt ou couche-tard ?

      13 mai 2014

      SANTÉ

      La génétique influence les effets du stress chronique

      6 novembre 2013

      THÉRAPiES

      Migraine vestibulaire et physiothérapie

      31 janvier 2021

      THÉRAPiES

      Les ostéopathes ne sont pas autorisés à pratiquer…

      4 janvier 2021

      THÉRAPiES

      La respiration abdominale comme thérapie ?

      4 janvier 2021

      THÉRAPiES

      La migraine et l’hygiène de vie

      12 juillet 2020

  • Info
    • FAQ
    • Ressources
    • Outils
    • Traitements
      • Médicaments
    • Commotion
  • Biblio
  • Exercices
  • Contact
CORPUS

Ce texte a une durée de lecture estimée à 55 minutes !5.1.11 Références

par Eric Rousseau 3 décembre 2021
3 décembre 2021
5. Migraine
5.1 Description
5.1.1 Classification
5.1.2 Les phases d’une crise
5.1.3 Facteurs déclenchants
5.1.4 Épidémiologie
5.1.5 Pathophysiologie
5.1.6 Composante génétique
5.1.7 Composante pharmacologique
5.1.8 Théorie du continuum
5.1.9 Intérêt de la physiothérapie
5.1.10 Conclusion
5.1.11 Références
5.2 Évaluation
5.3 Traitement
5.4 Particularités chez les femmes
5.5 Particularités chez les enfants
  1. Chua NH, et al. Differences in sensory processing between chronic cervical zygapophysal joint pain patients with and without cervicogenic headache. Cephalalgia 2011;31:953-963.
  2. Ashina M. Calcitonin gene-related peptide in tension-type headache. Scientific World J 2002;7(2):1527-31.
  3. Frese A, Schilgen M, Edvinsson L, Frandsen E, Evers S. Calcitonin gene-related peptide in cervicogenic headache. Cephalalgia 2005;25(9):700-3.
  4. Hubka MJ. Cervicogenic dysfunction in muscle contraction headache and migraine: a descriptive study. J manipul Physiol Ther 1993;16:428-431.
  5. Sjaastad O, Fredriksen T, Pareja Ja, et al. Coexistence of cervicogenic headache and migraine without aura. Funct Neurol 2000;14:209-218.
  6. Antonaci F, Fredriksen T, Sjaastad O. Cervicogenic headache: clinical presentation, diagnostic criteria and differential diagnosis. Curr Pain Headache Rep 2001;5:387-392.
  7. Sjaastad O, Fredriksen T, Pfaffenrath V. Cervicogenic headache: diagnostic criteria. Headache 1998;38:442-445.
  8. Cecchini AP, Sandrini G, Fokin I, et al. Trigeminofacial reflexes in primary headaches. Cephalalgia 2003;23:33-41.
  9. Milanov I, Bogdanova D. Trigemino-cervical reflex in patients with headache. Cephalalgia 2003:23:35-38.
  10. Nardone R, Tezzon F. The trigemino-cervical reflex in tension-type headache. Euro J Neurol 2003;10:307-312.
  11. Jull G, Amiri M, Bullock-Saxton J, et al. Cervical musculoskeletal impairment in frequent intermittent headache. Part 1: subjects with single headaches. Cephalalgia 2007;27:793-802.
  12. Jull G, Amiri M, Bullock-Saxton J, et al. Cervical musculoskeletal impairment in frequent intermittent headache. Part 2: subjects with multiple headaches. Cephalalgia 2007;27:891-898.
  13. Leone M, D’Amico D, Moschiano F, et al. Possible identification of cervicogenic headache among patients with migraine: an analysis of 374 headaches. Headache 1995;35:461-464
  14. Rokicki L, Semenchuk E, Bruehl S, et al. An examination of the validity of the IHS classification system for migraine and tension-type headache in the college student population. Headache 1999;39:720-727.
  15. Solomon S. Diagnosis of primary headache disorders: validity of the International Headache Society criteria in clinical practice. Neurol Clin 1997;15:15-26.
  16. Xiaobin Y, Cook A, Hamill-Ruth R, et al. Cervicogenic headache in patients with presumed migraine: missed diagnosis or misdiagnosis? J Pain 2005;6:700-703.
  17. Olesen J. Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain 1991;46:125-132.
  18. Bendtsen L. Central sensitization in tension-type headache – possible pathophysiological mechanisms. Cephalalgia 2000;20:486-508.
  19. Matharu M, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 2004;127:220-230.
  20. Zito G, Jull G, Story I. Clinical tests of musculoskeletal dysfunction in the diagnosis of cervicogenic headache. Man Ther 2006;11:118-129.
  21. Zwart JA. Neck mobility in different headache disorders. headache 1997;37:6-11.
  22. Marcus DA, Scharff L, mercer S, et al. Musculoskeletal abnormalities in chronic headache: a controlled comparison of headache diagnostic groups. Headache 1999;39:21-27.
  23. International Headache Society Classification Subcommittee. International classification of headache disorders, 2nd edition. Cephalagie 2004;24(Suppl 1):1-160
  24. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population – a prevaence study. J Clin Epidemiol 1991;44(11):1147-57.
  25. Hu XH, Markson LE, Lipton RB et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999;159(8):813-18.
  26. Andermann E, Andermann FA. Migraine-epilepsy relationships : epidemiological and genetic aspects. In: Andermann FA, Lugaresi E, eds. Migraine and epilepsy. Boston: Butterworths, 1987:281-91.
  27. Breslau N, Schultz LR, Stewart WF et al. Headache and major depression: is the association specific to migraine? Neurology 2000;54:308-13.
  28. Breslau N, Davis GC, Andeski P. Migraine, psychiatric disorders and suicide attempts: an epidemiological study of young adults. Psychiatry Res 1991;37:11-23.
  29. Rothrock J, North J, Madden K et al. Migraine and migrainous stroke: risk factors and prognosis. Neurology 1993;43:2473-6.
  30. Welch KMA. Relationship of stroke and migraine. Neurology 1994;44(suppl 7):33-6.
  31. Bové FJ. The story of Ergot. New York: Karger, 1970.
  32. Woakes E. On ergot of rye in the treatment of neuralgia. Br Med J 1868;2:360-1.
  33. Silberstein SD. The pharmacology of ergotamine and dihydroergotamine. Headache 1997;37:S15-S25.
  34. Rapoport AM. Acute treatment of migraine: established and emerging therapies.  Headache 2012;52(Suppl 2):60-4.
  35. Johnston M, Rapoport AM. Triptans for the management of migraine. CNS Drugs 2010;70:1505-1518
  36. Tfelt-Hansen P, Hougaard A. Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacity in the acute treatment of migraine. Expert Opin Drug Metab Toxicol 2013;9(1):91-103.
  37. Tfelt-Hansen P. Over-the-counter triptans for migraine: what are the implications? CNS Drugs 2007;21(11):877-83.
  38. Minet ML, Massiou H. An instrument to assess patient perceptions of satisfaction with acute migraine treatment (EXPERT Study). Headache 2011;51(4):590-601.
  39. Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002;42(Suppl 1):3-9.
  40. Lyndberg AC, Rasmussen BK, Jorgensen T, Jensen R. Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study. Eur J Epidemiol 2005;20(12):1007-14.
  41. Nappi G, Sandrini G, Sances G. Tolerability of the triptans: clinical implications. Drug Saf 2003;26(2):93-107.
  42. Dodick D, Lipton RB, Martin V et al. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache 2004;44(5):414-425.
  43. Lipton RB, Bigal ME, Diamond M et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68(5):343-349.
  44. Lucas C, Chaffaut C, Artaz MA, Lanteri-Minet M. FRAMIG 2000: medical and therapeutic management of migraine in France. Cephalalgia 2005;25(4):267–279.
  45. Morillo LE, Alarcon F, Aranaga N, et al. Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries. Headache 2005;45(2):118–126.
  46. Rizzoli PB. Acute and preventive treatment of migraine. Continuum 2012;18(4):764-82.
  47. Marcus DA, Scharff L, Mercer S, Turk DC. Nonpharmacological treatment for migraine: incremental utility of physical therapy with relaxation and thermal biofeedback. Cephalagia 1998;18(5):266-72.
  48. Parker GB, Tupling H, Pryor DS. A controlled trial of cervical manipulation for migraine. Aust NZJ Med 1978;8:589-593.
  49. Parker GB, Pryor DS, Tupling H. Why does migraine improve during a clinical trial? Further results from a trial of cervical manipulation for migraine. Aust NZB Med 1980;10:192-198.
  50. Nelson CF, Bronfort G, Evans R, Boline P, Goldsmith C, Anderson AV. The efficacity of spinal manipulations, amitryptiline and the combinaison of both therapies for the prophylaxis of migraine headache. J Manipulative Physiol Ther 1998;21:511-519.
  51. Tuchin PJ, Pollard H, Bonello R. A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. J Manipulative Physiol Ther 2000;23:91-95.
  52. Chaibi A, Tuchin PJ, Russel MB. Manual therapy for migraine: a systematic review. J Headache Pain 2011;12:127-133.
  53. Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine : current concepts and synthesis. Curr Pain Headache Reports 2003;7:371-376.
  54. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack. Brain 2000;123:1703-1709.
  55. Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. J Clin Neurol 2012;8:89-99.
  56. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996;384:560-563.
  57. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P. Origin of pain in migraine : evidence for peripheral sensitisation. Lancet 2009;8:679-690.
  58. Tommaso M, Sardaro M, Vecchio E, Serpino C, Stasi M, Ranieri M. Central sensitisation phenomena in primary headaches : overview of a preventive therapeutic approach. CNS Neurol Disord Drug Targets 2008;7:524-535.
  59. Bartsch T, Goadsby PJ. Stimulation of the greater occiptal nerve induces inceased central excitability of dural afferent input. Brain 2002;125:1496-1509.
  60. Bartsch T, Goadsby PJ. Increased response in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain 2003;126:1801-1813.
  61. Robertson BA, Moris ME. The role of cervical dysfunctions in migraine: a systematic review. Cephalagia 2008;28:474-483.
  62. Yi X, Cook AJ, Hamill-Ruth RJ, Rowlingson JC. Cervicogenic headache in patients with presumed migraine : missed diagnosis or misdiagnosis? J Pain 2005;6:700-703.
  63. Piovesan EJ, Werneck LC, Kowacs PA, Tatsui CE, Lange MC, Vincent M. Anesthetic blockade of the greater occipital nerve in migraine prophylaxis. Arg Neuropsiquiatr 2001;59:545-551.
  64. Weiner RL. Occipital neurostimulation for treatment of intractable headache syndrome. Acta Neurochir 2007;97:129-133.
  65. Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Int Neuromod Society 1999;2:217-221.
  66. Magis D, Gerardy PY, Remacle JM, Schoenen J. Sustained effectiveness of occipital nerve stimulation in drug-resistant chronic cluster headache. Headache 2011;51:1191-1201.
  67. Watson DH, Drummond PD. Head pain referral during examination of the neck in migraine and tension-type headache. Headache 2012;52:1226-1235.
  68. Luedtke K, Allers A, Schulte LH, May A. Efficacy of interventions used by physiotherapists for patients with headache and migraine: systematic review and meta-analysis. Cephalagia 2016;36:474-492.
  69. Luedtke K, Boissonnault W, Caspersen N, Castien R, Chaibi A, Falla D, et al. International consensus on the most useful physical examination tests used by physiotherpists for patients with headache: A Delphi study. Man Ther 2016;23:17-24.
  70. Robertson BA, Morris ME. The role of cervical dysfunction in migraine: a systematic review. Cephalalgia 2008;28:474-483.
  71. Ashina S, Bendtsen L, Lyngberg AC, Lipton RB, Hajiyeva N, Jensen R. Prevalence of neck pain in migraine and tension-type headache: a population study. Cephalalgia 2015;35:211-219.
  72. Vincent MB. Headache and neck. Curr Pain Headache Rep 2011;15:324-331.
  73. Evoy F. Vertiges d’origine centrale : sans anamnèse ni examen physique, point de diagnostic. Le Médecin du Québec 2005;40:33-41
  74. Bédard J. Vertiges vestibulaires périphériques : solutions et résolutions. Le Médecin du Québec 2005;40:45-52.
  75. Bédard J. Étourdissements et syncopes : comment ne pas tourner en rond? Le Médecin du Québec 2005;40:27-30.
  76. Clavet D. Vous dites que l’anxiété me rend étourdi, docteur? Le Médecin du Québec 2005;40:71-80.
  77. Wolff HG. Headache and Other Head Pain. 1948; New York: Oxford University Press.
  78. Wirth FP, van Buren JM. Referral of pain from dural stimulation in man. J Neurosurg 1971;34:630-642.
  79. Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain 2002;125:1496-1509.
  80. Kaube H, Katsarava Z, Kaufer T, Diener HC, Ellrich J. A new method to increase the nociception specificity of the human blink reflex. Clin Neurophysiol 2000;111:413-416.
  81. Li J, Simone DA, Larson AA. Windup leads to characteristics of central sensitization. Pain 1999;79:75-82.
  82. Cervero F. Fine afferent fibres from viscera and visceral pain: Anatomy and physiology of viscero-somatic convergence. In: Schmidt RF, Schaible HG, Vahle-Hinz C. Fine Afferent Nerve Fibers And Pain. 1987; Weinheim, Germany: VCH.
  83. Cervero F, Laird JM. Visceral Pain. Lancet 1999;353:2145-2148.
  84. Herrero JF, Laird JM, Lopez-Garcia JA. Wind-up of spinal cord neurones and pain sensation: Much ado about something? Prog Neurobiol 2000;61:169-203.
  85. Bolton S, O’Shaughnessy CT, Goadsby PJ. Properties of neurons in the trigeminal nucleus caudalis responding to noxious dural and facial stimulation. Brain Res 2005;1046:122-129.
  86. Bronfort G, Nilsson N, Haas M, et al. Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev 2004;3:CD001878.
  87. Biondi DM. Physical treatments for headache: A structured review. Headache 2005;45:738-746.
  88. Fernandez-de-las-Penas C, Alonos-Blanco C, Cuadrado ML, Miangolarra JC, Barriga FJ, Pareja JA. Are manual therapies effective in reducing pain from tension-type headache? A systematic review. Clin J Pain 2006;22:278-285.
  89. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study. Lancet 2015;386:743-800.
  90. Pearce JMS. Historical aspects of migraine. J Neurol Neurosurg Psych 1986;49:1097-1103.
  91. Sacks O. Migraine: Evolution of a common disorder. 1970; Londres: Faber & Faber.
  92. Lyons A, Petrucelli RJ. Medicine: an illustrated history. 1978; New York: Harry N. Abrams Inc.
  93. Silberstein SD, McCrory DC. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache 2003;43:144–166.
  94. Silberstein SD. The pharmacology of ergotamine and dihydroergotamine. Headache 1997;37:S15-S25.
  95. Silberstein SD, Lipton R, Goadsby P. Headache in Clinical Practice 2nd Edition. 2002; Informa HealthCare.
  96. Moskowitz MA. The visceral organ brain: Implications for the pathophysiology of vascular head pain. Neurology 1991;41:182-186.
  97. Mehle ME. Migraine and allergy: A review and clinical update. Curr Allergy Asthma Rep 2012;12:240-245.
  98. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (Beta version). Cephalalgia 2013;33:629-808.
  99. Prakash S, Rathore C, Makwana P, Rathod M. Recurrent spontaneous paresthesia in the upper limb could be due to migraine: A case series. Headache 2015;55:1143-1147.
  100. Dubé Y. Ces yeux qui nous parlent. Le Médecin du Québec 2007;42:21-29.
  101. Winawer MR, Connors R. Evidence for a shared genetic susceptibility to migraine and epilepsy. Epilepsia 2013;54:288-295.
  102. Mantegazza M, Cestèle S. Pathophysiological mechanisms of migraine and epilepsy: Similarities and differences. Neurosci Lett 2017:S0304-S3940 [Epub ahead of print].
  103. Couch JR, Diamond S. Status migrainosus: causative and therapeutic aspects. Headache 1983;23:94-101.
  104. Katsarava Z, Schneeweiss S, Kurth H et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004;62:788-790.
  105. Scher AI, Stewart WF, Ricci JA et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003;106:81-89.
  106. Solomon S, Lipton RB, Newman LC. Clinical features of chronical daily headache. Headache 1992;32:325-329.
  107. Tzourio C, Iglesias S, Tehindrazanarivelo A et al. Migraine and ischemic stroke in young women. Stroke 1994;25:15.
  108. Alvarez J, Matias-Guiu J, Sumulla J. Ischemic stroke in young adults: analysis of etiological subgroups. Acta Neurol Scand 1989;80:29-34.
  109. Bale JL. Les céphalées primaires de l’enfant: Diagnostic et traitement. Paediatrica 2007;18:39-44.
  110. Winner P, Hershey AD. Diagnosing migraine in the pediatric population. Curr Pain Headache Reports 2006;10:363-369.
  111. Lewis DW. Pediatric Migraine. Pediatrics in Review 2007;28:43-53.
  112. Balottin U, Termine C, Nicoli F, et al. Idiopathic headache in children under six years of age: A follow-up study. Headache 2005;45:705-715.
  113. Stolte B, Holle D, Naegel S, Diener HC, Obermann M. Vestibular migraine. Cephalalgia 2015;35:262-270.
  114. Lauritsen CG, Marmura MJ. Current treatment options: Vestibular migraine. Curr Treat Options Neurol 2017;19:38.
  115. Vukovic V, et al. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache 2007;47:1427-1435.
  116. Faucher S, Le Heuzey MF, Rouyer V, Mouren-Simeoni MC. À propos du syndrome des vomissements cycliques. Archives de pédiatrie 2003;10:385-391.
  117. Bisdorff AR. Management of vestibular migraine. Ther Adv Neurol Disord 2011;4:183-191.
  118. Bigal ME, Lipton RB. What predicts the change from episodic to chronic migraine? Curr Opin Neurol 2009;22:269-276.
  119. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States: Relation to age, income, race, and other sociodemographic factors. JAMA 1992;267:64-69.
  120. May A, Schulte LH. Chronic migraine: Risk factors, mechanisms and treatment. Nature Reviews 2016;12:455-464.
  121. Buse DC, et al. Chronic migraine prevalence, disability, and sociodemographic factors: Results from the American Migraine Prevalence and Prevention Study. Headache 2012;52:1456-1470.
  122. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalagia 2007; 27:193-210.
  123. Gilmour H, Ramage-Morin PL. Prevalence of migraine in the Canadian household population. https://www.statcan.gc.ca/pub/82-003-x/2014006/article/14033-eng.htm. Visité le 23 novembre 2017.
  124. Sharav Y, Benoliel R. Orofacial Pain and Headache. 2008; Mosby.
  125. Netter FH. The Netter’s Collection of Medical Illustrations Vol. 7 The Nervous System, Part I: The Brain, 2nd Edition 2013; Philadelphia: Elsevier Saunders.
  126. Silberstein SD, Stiles A, Young WB, Rozen TD. An Atlas of Headache. 2002 : The Parthenon Publishing Group.
  127. Pellegrino ABW, Davis-Martin RE, Houle TT, Smitherman TA. Perceived triggers of primary headache disorders: A meta-analysis. Cephalalgia 2017;333102417727535 [Epub ahead of print].
  128. Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci 2017;372:307-315.
  129. Cutrer FM, Moskowitz MA. Physiopathologie de la migraine. 2005; Paris.
  130. Gatt MT, Belin C. Migraines: Points de vue d’un neurologue et d’un médecin de la douleur. Revue Française Psychosom 208;34:87-96.
  131. Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev 2017;97:553-622.
  132. Charles A. Migraine: A brain state. Curr Opin Neurol 2013;26:235-239.
  133. Ferrari MD, Klever RR, Terwindt GM, et al. Migraine pathophysiology: Lessons from mouse models and human genetics. Lancet Neurol 2015;14:65-80.
  134. Puledda F, Messina R, Goadsby PJ. An update on migraine: Current understanding and future directions J Neurol 2017;264:2031-2039.
  135. Goadsby PJ, Hoskin KL. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: A c-Fos immunocytochemical study. J Anat 1997;190(Pt 3):367-375.
  136. Hoskin KL, Zagami A, Goadsby PJ. Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: A comparative study of monkey and cat. J Anat 1999;194:579-588.
  137. Messlinger K, Fischer MJ, Lennerz JK. Neuropeptide effects in the trigeminal system: Pathophysiology and clinical relevance in migraine. Keio J Med 2011;60:82-89.
  138. Ho TW, Edvinsson L, Goadsby PJ. CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 2010;6:573-582.
  139. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neurobiology of migraine. Neuroscience 2009;161:327-341.
  140. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci 2011;12:570-584.
  141. Moskowitz MA, Cutrer FM. Sumatriptan: A receptor-targeted treatment for migraine. Annu Rev Med 1993;44:145-154.
  142. Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated leakage of plasma proteins occurs from blood vessels in dura mater but not brain. J Neurosci 1987;7:4129-4136.
  143. May A, Goadsby PJ. Substance P receptor antagonists in the therapy of migraine. Expert Opinion Investig Drugs 2001;10:1-6.
  144. Peroutka SJ. Neurogenic inflammation and migraine: Implications for therapeutics. Mol Interv 2005;5:306-313.
  145. Raskin NH, Hosobuchi Y, Lamb S. Headache may arise from perturbation of brain. Headache 1987;27:416-420.
  146. Weiller C, May A, Limmroth V, Juptner M, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995;1:658-660.
  147. Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 2001;357:1016-1017.
  148. Stankewitz A, Aderjan D, Eippert F, May A. Trigeminal nociceptive transmission in migraineurs predicts migraine attacks. J Neurosci 2011;31:1937-1943.
  149. Goadsby PJ, Duckworth JW. Low frequency stimulation of the locus coeruleus reduces regional cerebral blood flow in the spinalized cat. Brain Res 1989;476:71-77.
  150. Vinogradova LV. Comparative potency of sensory-induced brainstem activation to trigger spreading depression and seizures in the cortex of awake rats: Implications for the pathophysiology of migraine aura. Cephalalgia 1995;35:979-986.
  151. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci 2011;12:570-584.
  152. Borsook D, Burstein R. The enigma of the dorsolateral pons as a migraine generator. Cephalalgia 2012;32:803-812.
  153. Kroger IL, May A. Triptan-induced disruption of trigemino-cortical connectivity. Neurology 2015;84:2124-2131.
  154. Goadsby PJ, Hoskin KL. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutic target in migraine? Pain 1996;67:355-359.
  155. Goadsby PJ, Gundlach AL. Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: Relevance to migraine. Ann Neurol 1991;29:91-94.
  156. Hoskin KL, Kaube H, Goadsby PJ. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain 1996;119(Pt 1):249-256.
  157. Pozo-Rosich P, Storer RJ, Charbit AR, Goadsby PJ. Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons. Cephalalgia 2015;35:1298-1307.
  158. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 2004;142:1171-1181.
  159. May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998;352:275-278.
  160. Goadsby PJ. Trigeminal autonomic cephalalgias. Continuum 2012;18:883-895.
  161. May A. Cluster headache: Pathogenesis, diagnosis, and management. Lancet 2005;366:843-855.
  162. Kagan R, Kainz V, Burstein R, Noseda R. Hypothalamic and basal ganglia projections to the posterior thalamus: Possible role in modulation of migraine headache and photophobia. Neuroscience 2013;248:359-368.
  163. Abdallah K, Artola A, Monconduit L, Dallel R, Luccarini P. Bilateral descending hypothalamic projections to the spinal trigeminal nucleus caudalis in rats. PLoS One 2013;8:e73022.
  164. Robert C, Bourgeais L, Arreto CD, et al. Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches. J Neurosci 2013;33:8827-8840.
  165. Moulton EA, Becerra L, Johnson A, Burstein R, Borsook D. Altered hypothalamic functional connectivity with autonomic circuits and the locus coeruleus in migraine. PLoS One 2014;9:e95508.
  166. Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache 2007;47:1418-1426.
  167. Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain 2014;137:232-241.
  168. Schulte LH, May A. The migraine generator revisited: Continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain 2016;139:1987-1993.
  169. Oliveira MM, Akerman S, Tavares I, Goadsby PJ. Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: Implications for migraine. Pain 2016;157:1666-1673.
  170. Noseda R, Jakubowski M, Kainz V, Borsook D, Burstein R. Cortical projections of functionally identified thalamic trigeminovascular neurons: Implications for migraine headache and its associated symptoms. J Neurosci 2011;31:14204-14217.
  171. Noseda R, Kainz V, Borsook D, Burstein R. Neurochemical pathways that converge on thalamic trigeminovascular neurons: Potential substrate for modulation of migraine by sleep, food intake, stress and anxiety. PLoS One 2014;9:e103929.
  172. Messina R, Rocca MA, Colombo B, et al. White matter microstructure abnormalities in pediatric migraine patients. Cephalalgia 2015;35:1278-1286.
  173. Coppola G, Tinelli E, Lepre C, Iacovelli E, et al. Dynamic changes in thalamic microstructure of migraine without aura patients: a diffusion tensor magnetic resonance imaging study. Eur J Neurol 2014;21:287-e13.
  174. Magon S, May A, Stankewitz A, Goadsby PJ, et al. Morphological abnormalities of thalamic subnuclei in migraine: A multicenter MRI study at 3 tesla. J Neurosci 2015;35:13800-13806.
  175. Porcaro C, Di Lorenzo G, Seri S, Pierelli F, Tecchio F, Coppola G. Impaired brainstem and thalamic high-frequency oscillatory EEG activity in migraine between attacks. Cephalalgia 2017;37:915-926.
  176. Hodkinson DJ, Wilcox SL, Veggeberg R, et al. Increased amplitude of thalamo-cortical low-frequency oscillations in patients with migraine. J Neurosci 2016;36:8026-8036.
  177. Afridi SK, Matharu MS, Lee L, Kaube H, et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 2005;128:932-939.
  178. Afridi SK, Giffin NJ, Kaube H, et al. A positron emission tomographic study in spontaneous migraine. Arch Neurol 2005;62:1270-1275.
  179. Noseda R, Kainz V, Jakubowski M, Gooley JJ, et al. A neural mechanism for exacerbation of headache by light. Nat Neurosci 2010;13:239-245.
  180. Burstein R, Jakubowski M, Garcia-Nicas E, et al. Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol 2010;68:81-91.
  181. Shields KG, Goadsby PJ. Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: A role in migraine? Brain 2005;128:86-97.
  182. Tepe N, Filiz A, Dilekoz E, Akcali D, Sara Y, Charles A, Bolay H. The thalamic reticular nucleus is activated by cortical spreading depression in freely moving rats: Prevention by acute valproate administration. Eur J Neurosci 2015;41:120-128.
  183. Andreou AP, Shields KG, Goadsby PJ. GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus. Neurobiol Dis 2010;37:314-323.
  184. Summ O, Charbit AR, Andreou AP, Goadsby PJ. Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus. Brain 2010;133:2540-2548.
  185. Bhaskar S, Saeidi K, Borhani P, Amiri H. Recent progress in migraine pathophysiology: Role of cortical spreading depression and magnetic resonance imaging. Eur J Neurosci 2013;38:3540-3551.
  186. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001;98:4687-4692.
  187. Ayata C, Lauritzen M. Spreading depression, spreading depolarizations, and the cerebral vasculature. Physiological Reviews 2015;95:953-993.
  188. Santos E, Schöll M, Sánchez-Porras R, et al. Radial, spiral and reverberating waves of spreading depolarization occur in the gyrencephalic brain. NeuroImage 2014;99:244-255.
  189. Terra VC, Cysneiros R, Cavalheiro EA, Scorza FA. Sudden unexpected death in epilepsy: From the lab to the clinic setting. Epilepsy & Behavior 2013;26:415-20.
  190. Sprenger T, Borsook D. Migraine changes the brain: Neuroimaging makes its mark. Curr Opin Neurol 2012;25:252-262.
  191. Chong CD, Schwedt TJ, Dodick DW. Migraine: What imaging reveals. Curr Neurol Neurosci Rep 2016;16:64.
  192. Coppola G, Di Lorenzo C, Schoenen J, Pierelli F. Habituation and sensitization in primary headaches. J Headache Pain 2013;14:65
  193. Ambrosini A, Rossi P, De Pasqua V, Pierelli F, Schoenen J. Lack of habituation causes high intensity dependence of auditory evoked cortical potentials in migraine. Brain 2003;126:2009-2015.
  194. Afra J, Cecchini AP, De Pasqua V, Albert A, Schoenen J. Visual evoked potentials during long periods of pattern-reversal stimulation in migraine. Brain 1998;121(Pt 2):233-241.
  195. Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain 2016;139:2002-2014.
  196. Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: A randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol 2010;9:373-380.
  197. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002;8:136-142.
  198. Zhang X, Levy D, Kainz V, Noseda R, Jakubowski M, Burstein R. Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol 2011;69:855-865.
  199. Piane M, Lulli P, Farinelli I, Simeoni S, et al. Genetics of migraine and pharmacogenomics: Some considerations. The journal of headache and pain 2007;8:334-339.
  200. Gasparini CF, Smith RA, Griffiths LR. Genetic insights into migraine and glutamate: A protagonist driving the headache. J Neurol Sci 2016;367:258-268.
  201. Freilinger T, Anttila V, de Vries B, Malik R, et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 2012;44:777-782.
  202. Estevez M, Gardner KL. Update on the genetics of migraine. Hum Genet 2004;114:225-235.
  203. Nelson CF. The tension headache, migraine headache continuum: A hypothesis. J Manipulative Physiol Ther 1994;17:156-67.
  204. Peres MFP, Gonçalves AL, Krymchantowski A. Migraine, Tension-type Headache, and Transformed Migraine. Curr Pain Headache Rep 2007;11:449-453.
  205. Shevel E. The migraine/tension-type headache continuum. South Afric Med J 2000;90:869-871.
  206. Vincent MB, Luna RA. Cervicogenic headache: A comparison with migraine and tension-type headache. Cephalalgia 1999;19(Suppl 25):11-16.
  207. Pryse-Phillips W, Findlay H, Tugwell P, et al. A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 1992;19:333-339.
  208. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Incidence of primary headache: A Danish epidemiologicfollow-up study. Am J Epidemiol 2005;161:1066-1073.
  209. Robertson BA, Morris ME. The role of cervical dysfunction in migraine: A systematic review. Cephalalgia 2008;28:474-483.
  210. Luedtke K, Starke W, May A. Musculoskeletal dysfunction in migraine patients. Cephalalgia 2017:333102417716934 [Epub ahead of print].
  211. Florencio LL, de Oliveira AS, Carvalho GF, Dach F, et al. Association Between Severity of Temporomandibular Disorders and the Frequency of Headache Attacks in Women With Migraine: A Cross-Sectional Study. J Manipul Physiol Ther 2017;40:250-254.
  212. Bogduk N. The anatomical basis for cervicogenic headache. J Manipulative Physiol Ther 1992;15:67-70.
  213. Becker WJ. Cervicogenic headache: evidence that the neck is a pain generator. Headache 2010;50:699-705.
  214. Hunter CR, Mayfield FH. Role of the upper cervical roots in the production of pain in the head. Am J Surg 1949;78:743-749.
  215. Johnston M, Jordan SE, Charles AC. Pain referral patterns of the C1 to C3 nerves: Implications for headache disorders. Ann Neurol 2013;74:145-8.
  216. Cremer P, halmagyi GM, Goadsby PJ. Secondary cluster headache responsive to sumatriptan. J Neurol Neurosurg Psychiatry 1995;59:633-34.
  217. Hutchinson PJ, Pickard JD, Higgins JN. Vertbral artery dissection presenting as cerebellar infarction. J Neurol Neurosurg Psychiatry 2000;68:98-99.
  218. Piovesan EJ, Kowacs PA, Tatsui CE, et al. Reffered pain after painful stimulation of the greater occipital nerve in humans: Evidence of convergence of cervical afferents on trigeminal nuclei. Cephalagia 2001;21:107-109.
  219. Feinstein B, Langton JN, Jameson RM, Schiller F. Experiments on pain reffered from deep somatic tissues. J Bone Joint Surg 1954;36-A:981-997.
  220. Bogduk N. Cervicogenic headache: Anatomical basis and pathophysiology mechanisms. Curr Pain Headache Rep 2001;5:382-386.
  221. von Piekartz, Hall T. Orofacial manual therapy improves cervical movement impairment associated with headache and features of temporomandibular dysfunction: a randomized controlled trial. Man Ther 2013;18:345-50.
  222. von Piekartz, Ludtke K. Effect of treatment of temporomandibular disorders (TMD) in patients with cervicogenic headache: a single-blind, randomized controlled study. Cranio 2011;29:43-56.
  223. DeFranca GG, Levine LJ. « The T4 syndrome. » J Manipulative Physiol Ther 1995;18:34-7.
  224. Schueler M, Neuhuber WL, de Col R, Messlinger K. Inervation of rat and human dura mater and pericranial tissues in the parieto-temporal region by meningeal afferents. Headache 2014;54:996-1009.
  225. Butler DS. The sensitive Nervous System. 2000; Adelaide: NOI Group.
  226. Joel Saper. Neck and Migraine: What’s the connection? https://www.migraineworldsummit.com/public-joel-saper. Accédé le 28 avril 2017.
  227. Thorsten B, Goadsby PJ. The trigeminocervical complex and migraine. In: Fernandez-de-las-Penas C, Chaitow L, Schoenen J. Multidisciplinary management of migraine. 2013; Burlington MA: Jones & Bartlett Learning.
  228. Behbehani MM. Functionnal characeristics of the midbrain periaqueductal gray. Prog Neurobiol 1995;46:575-605.
  229. Fields H. State-dependant opioid control of pain. Nat Rev Neurosci 2004;5:565-575.
  230. SandKuhler J, Fu QG, Zimmermann M. Spinal pathways mediating tonic or stimulation-produced descending inhibition from the periaqueductal gray or nucleus raphe magnus are separate in the cat. J Neurophysiol 1987;58:327-341.
  231. de Tomasso M, Capuano A, Valeriani M. Peripheral and central sensitization mechanisms in migraine. In: Fernandez-de-las-Penas C, Chaitow L, Schoenen J. Multidisciplinary management of migraine. 2013; Burlington MA: Jones & Bartlett Learning.
  232. Giniatullin R, Nistri A, Fabbretti E. Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF. Mol Neurobiol 2008;37:83-90.
  233. Crépel F, Lemaire G. Le monoxyde d’azote. Revue MS 1995;11:1639-1642.
  234. Thomsen LL, Olesen J. Nitric oxide in primary headaches. Curr Opin Neurol 2001;14:315-321.
  235. Akerman S, Williamson DJ, Kaube H, Goadsby PJ. Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural miningeal vessels. Br J Pharmacol 2002;137:62-68.
  236. Lambert Ga, Boers PM, Hoskin KL, Donaldson C, Zagami AS. Suppression by eletriptan of the activation of trigeminovascular sensory neurons by glyceryltrinitrate. Brain Res 2002;953:181-188.
  237. Borkum JM. Migraine Triggers and Oxidative Stress: A Narrative Review and Synthesis. Headache 2016;56:12-35.
  238. Isler H. Thomas Willis’ chapters on headache of 1672. Headache 1986;25:95-98.
  239. Schoonman GG, van der Grond J, Kortmann C, et al. Migraine headache is not associated with cerebral or meningeal vasodilatation: A 3T magnetic resonance angiography study. Brain 2008;131:2192-2200.
  240. Schoenen J, Ambrosini A, Sandor PS, Maertens de Noordhout A. Evoked potentials ans transcranial magnetic stimulation in migraine: Published data and viewpoint on their pathophysiologic signifiance. Clin Neurophysiol 2003;114:955-972.
  241. Aurora SK, Barrodale P, Chronicle EP, Mulleners WM. Cortical inhibition is reduced in chronic and episodic migraine and demonstrated a spectrum of illness. Headache 2005;45:546-552.
  242. Coppola G, Ambrosini A, Di Clemente L, et al. Interictal abnormalities of gamma band activity in visual evoked responses in migraine: An indication of thalamocortical dysrhytmia? Cephalalgia 2007;27:1360-1367.
  243. Gantenbein A, Sandor P, Riederer F, Schoenen J. A comprehensive view of migraine pathophysiology. In: Fernandez-de-las-Penas C, Chaitow L, Schoenen J. Multidisciplinary management of migraine. 2013; Burlington MA: Jones & Bartlett Learning.
  244. Pardutz A, Multon S, Malgrange B, et al. Effect of nitroglycerin on CGRP and 5-HTafferents to rat caudal spinal trigeminal nucleus and its modulation by oestrogen. Eur J Neurosci 2002;15:1803-1809.
  245. Multon S, Pardutz A, Mosen J, et al. Lack of oestrogen increases pain in the trigeminal formalin model: A behavioural and immunocytochemical study of transgenic ArKO mice. Pain 2005;114:257-265.
  246. Gupta S, Mehrotra S, Villalon CM, et al. Potntial role of female sex hormones in the pathophysiology of migraine. Pharmacol Therap 2007;113:321-340.
  247. MacGregor EA. Menstrual migraine. Curr Opin Neurol 2008;21:309-315.
  248. Letizia-Mauro G, Cataldo P, Barbera G, Sanfilippo A. α-Lipoic acid and superoxide dismutase in the management of chronic neck pain: A prospective randomized study. Drugs in R&D 2014;14:1-7.
  249. Alp R, Selek S, Alp IS, Taşkin A, Koçyigit A. Oxidative and antioxidative balance in patients of migraine. Eur Rev Med Pharm Sci 2010;14:877-882.
  250. Kolberg C, Horst A, Moraes MS, et al. Peripheral oxidative stress blood markers in patients with chronic back or neck pain treated with high-velocity, low-amplitude manipulation. J Manipul Physiol Ther 2015;38:119-129.
  251. Ford ES, Li C, Pearson WS, Zhao G, Strine TW, Mokdad AH. Body mass index and headaches: findings from a national sample of US adults. Cephalalgia 2008;28:1270-1276.
  252. Peterlin BL, Rosso AL, Rapoport AM, Scher AI. Obesity and Migraine: The Effect of Age, Gender and Adipose Tissue Distribution. Headache 2010;50:52-62.
  253. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology 2006;66:545-550.
  254. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 2006;67:252-257.
  255. Bigal ME, Tsang A, Loder E, Serrano D, Reed ML, Lipton RB. Body mass index and episodic headaches: a population-based study. Arch Intern Med 2007;167:1964-1970.
  256. Schuster NM, Rapoport AM. New strategies for the treatment and prevention of primary headache disorders. Nature Reviews Neurology 2016;12:635-650.
  257. Bharadwaj VN. Porreca F, Cowan RP, et al. A new hypothesis linking oxytocin to menstrual migraine. Headache 2021;61:1051-1059.
  258. Noseda R, Burstein R. Advances in understanding the mechanisms of migraine-type photophobia. Current Opinion in Neurology. 2011;24:197-202.
  259. Noseda R, Melo-Carrilo A, Nir R-R, et al. Non-trigeminal nociceptive innervation of the posterior dura: Implications to occipital headache. J Neurosci 2019;39:1867-1880.
  260. Lv X, Wu Z, Li Y. Innervation of the cerebral dura mater. Neuroradiol J 2014;27:293-298.
  261. Waldie KE, Buckley J, Bull PN, Poulton R. Tension-type headache: A life-course review. J Headache Pain Manag 2015;1:1.
  262. de Goffau MJ, Klaver ARE, Willemsen MG, Bindels PJE, Verhagen AP. The Effectiveness of Treatments for Patients With Medication Overuse Headache: A Systematic Review and Meta-Analysis. Pain 2017;18:615-627.
  263. Munksgaard SB, Bendtsen L, Jensen RH. Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: A comparison of two consecutive treatment methods in an open-label design. Cephalalgia 2012;32:834-844.
  264. Sanchez-Manso JC, Aleksenko D. Headache, medication Overuse. 2017; StatPearls.
  265. Clinch CR. Evaluation of acute headaches in adults. Am Fam Phys 2001;63:685-692.
  266. Gormley P, Anttila V, Winsvold BS, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet 2016;48:856-866.
  267. Nyholt DR, van den Maagdenberg AM. Genome-wide association studies in migraine: Current state and route to follow. Curr Opin Neurol 2016;29:302-308.
  268. Peris F, Donoghue S, Torres F, et al. Towards improved migraine management : Determining potential trigger factors in individual patients. Cephalalgia 2017;37:452-463.
  269. Watson DH, Drummond PD. Head pain referral during examination of the neck in migraine and tension-type headache. Headache J Head face Pain 2012;52:1226-1235.
  270. Ogince M, Hall T, Robinson K, et al. The diagnostic validity of the cervical flexion-rotation test in C1/2-related cervicogenic headache. Man Ther 2007;12:256-262.
  271. Russo A, Silvestro M, Tessitore A, Tedeschi G. Recent insights in migraine with aura : A narrative review of advanced neuroimaging. Headache 2019;59:637-649.
  272. Nahman-Averbuch HN, Shelfi T, Schneider VJ, et al.  Quantitative sensory testing in patients with migraine: A systematic review and meta-analysis. Pain 2018;159:1202-1223.
  273. Schueler M, Messlinger K, Dux M, Neuhuber WL, De Col R. Extracranial projections of meningeal afferents and their impact on meningeal nociception and headache. Pain 2013;154:1622-1631.
  274. Burstein R, Blake P, Schain A, Perry C. Extracranial origin of headache. Curr Opin Neurol 2017;30:263-271.
  275. Jakubowski M, et al. Exploding vs imploding headache in migraine prophylaxis with Botulinum toxin A. Pain 2006;125:286-295.
  276. Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R. Activation of meningeal nociceptors by cortical spreading depression: Implications for migraine with aura. J Neurosci 2011;30:8807-8814.
  277. Roch M, Messlinger K, Kulchitsky V, et al. Ongoing activity in trigeminal wide-dynamic range neurons is driven from the periphery. Neurosci 2007;150:681-691.
  278. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain 2001;120:3779-3787.
  279. Goadsby PJ, Bartsch T. On the functional neuroanatomy of neck pain. Cephalalgia 2008;28(Suppl 1):1-7.
  280. Nöbel M, Feistel S, Ellrich J, Messlinger K. ATP-sensitive muscles afferents activate spinal trigeminal neurons with meningeal afferent input in rat – pathophysiological implications for tension-type headache. J Headache Pain 2016;17:75.
  281. Villanueva L, Cadden SW, Le Bars D. Diffuse noxious inhibitory controls (DNIC) : evidence for post-synaptic inhibition of trigeminal nucleus caudalis convergent neurons. Brain Res 1984;321:165-168.
  282. Bouhassira D, Le Bars D, Villanueva L. Heterotopic activation of A delta and C fibres triggers inhibition of trigeminal and spinal convergent neurons in the rat. J Physiol 1987;389:301-317.
  283. Clement CI, Keay KA, Podzebenko K, Gordon BD, Bandler R. Spinal sources of noxious visceral and noxious deep somatic afferent drive onto the ventrolateral periaqueductal gray of the rat. J Comp Neurol 2000;425:323-344.
  284. Moutpn LJ, Klop EM, Holstege G. C1-C3 spinal cord projections to periaqueductal gray and thalamus: A quantitative retrograde tracing study in cat. Brain Res 2005;1043:87-94.
  285. Busch V, Jacob W, Juergens T, et al. Functional connectivity between trigeminal and occipital nerves revealed by occipital nerve blockade and nociceptive blink reflexes. Cephalalgia 2006;26:50-55.
  286. Castien R, De Hertogh W. A neuroscience perspective of physical treatment of headache and neck pain. Frontiers Neurol  2019;10:276.
  287. Luedtke K, May A. Stratifying migraine patients based on dynamic pain provocation over the upper cervical spine. J Headache Pain 2017;18:97.
  288. Bragatto MM, Bevilaqua-Grossi D, Benatto MT, et al. Is the presence of neck pain associated with more severe clinical presentation in patients with migraine? A cross-sectional study. Cephalalgia 2019;39:1500-1508.
  289. Liang Z, Galea O, Thomas L, et al. Cervical musculoskeletal impairments in migraine and tension-type headache: A systematic review and meta-analysis. Musculoskel Sci Pract 2019;42:67-83.
  290. Szikszay TM, Hoenick S, von Korn K, et al. Which examination tests detect differences in cervical musculoskeletal impairments in people with migraine? A systematic review and meta-analysis.  Phys Ther 2019;99:549-569.
  291. Viana M, Sances G, Terrazzino S, et al. When cervical pain is actually migraine: An observational study in 207 patients. Cephalalgia 2018;38:383-388.
  292. Johnston MM, Jordan SE, Charles AC. Pain referral patterns of the C1 to C3 nerves: implications for headache disorders. Ann Neurol 2013;74:145-148.
  293. Charles A. The pathophysiology of migraine: Implications for clinical management. Lancet Neurol 2018;17:174-182.
  294. Kemp WJ, Tubbs RS, Cohen-Gadol AA. The innervation of the cranial dura mater: Neurosurgical case correlates and a review of the literature. World Neurosurg 2012;78:505-510.
  295. Prakash S, Rathore C. side-locked headaches : An algorithm-based approach. Headache Pain 2016;17:95.
  296. Ramon C, Mauri G, Vega J, et al. Diagnostic distribution of 100 unilateral, side-locked headaches consulting a specialized clinic. European Neurology 2013;69:289-291.
  297. Hvedstrup J, Kolding LT, Ashina M, Schytz W. Increased neck muscle stiffness in migraine patients with ictal neck pain: A shear wave elastography study. Cephalalgia 2020;40:565-574.
  298. Stefanik JJ, Frey-Law L, Segal NA, et al. The relation of peripheral and central sensitization to muscle co-contraction: The MOST study. Osteoarthritis Cartilage 2020;S1063-4584(20)31053.
  299. Carlsen LN, Munksgaard SB, Nielsen M, et al. Comparison of 3 treatment strategies for medication overuse headache : A randomized clinical trial. JAMA Neurol 2020 [Ahead of print].
  300. Niddam DM, Lai KL, Tsai SÙY, et al. Brain metabolites in chronic migraine patients with medication overuse headache. Cephalalgia 2020;40:851-862.
  301. Arca KN, Singh RBH. The hypertensive headache: A review. Curr Pain Headache Rep 2019;23:30.
  302. Scholten-Peeters GGM, Coppieters MW, Durge TSC, Castien RF. Fluctuations in local and widespread mechanical sensitivity throughout the migraine cycle: a prospective longitudinal study. J Headache Pain 2020;21:16.
  303. Leroux E. La Migraine: Au-Delà du Mal de Tête. 2015; Montréal: Les Éditions du Trécarré.
  304. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008;7:354-361.
  305. Karsan N, Goadsby PJ. Biological insights from the premonitory symptoms of migraine. Nature Reviews Neurol 2018;14:699-710.
  306. Ko MW, Prasad S. Headache, facial pain, and disorders of facial sensation. In: Liu GT, Volpe NJ, Galetta SL. Liu, Volpe, and Galetta’s neuro-ophtalmology: Diagnosis and management, 3rd edition. 2018: Elsevier.
  307. Arickx AN. Overview of headache. In: Mitra R. Principles of rehabilitation medicine. 2019: McGraw-Hill Education.
  308. Krishnaswamy R, Malik BH, Khan S, et al. Anti-CGRP monoclonal antibodies: Breakthrough in migraine therapeutics. Prog Neurol Psych 2019;23:26-33.
  309. Toriyama T, Horiuchi T, Hongo K. Characterization of migraineurs presenting interictal widespread pressure hyperalgesia identified using a tender point count: a cross-sectional study. J Headache Pain 2017;18 :117.
  310. Rizzo AC, Paolucci M, Altavilla R, et al. Daith piercing in a case of chronic migraine: A possible vagal modulation. Front Neurol 2017;8:624.
  311. Bhandari P, Ranjit E, Sapra A, et al. Daith peircing :Wonder treatment or untested fad? Cureus 2020;12:e6978.
  312. Torres-Yaghi Y, Salerian J, Dougherty C. Cardia cephalgia. Curr Pain Headache Rep 2015;19:14.
  313. Lipton RB, Seng EK, Chu MK, et al. The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache 2020;60:1683-1696.
  314. Wongtrakul W, Charoenngam N, Ungprasert P. Increased prevalence of irritable bowel syndrome in migraine patients: A systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2021 [Ahead of print].
  315. Liang Z, Thomas L, Jull G, et al. Neck pain associtaed with migraine does not necessarily reflect cervical musculoskeletal dysfunction. Headache 2021;61:882-894.
  316. Aoyama N. Involvement of cervical disability in migraine: a literature review. Br J Pain 2021;15:199-212.
  317. Young AS, Nham B, Bradshaw AP, et al. Clinical oculographic, and vestibular test characteristics of vestibular migraine. Cephalalgia 2021 [Ahead of print].
  318. Ashina M. Migraine. N Engl J Med 2020;383:1866-1876.
  319. Alpuente A, Gallardo VJ, Asskour L, et al. Salivary CGRP can monitor the different migraine phases: CGRP in(dependant) attacks. Cephalalgia 2021 [Ahead of print].
  320. Ahn AH. On the temporal relationship between throbbing migraine pain and arterial pulse. Headache 2010;50:1507-1510.
  321. Mirza AF, Mo J, Holt JL, et al. Is there a relationship between throbbing pain and arterial pulsations? J Neurosci 2012;32:7572-7576.

POURSUiVRE

5.2 Évaluation

Évaluation physiothérapeutique détaillée propre à la migraine.

par Eric Rousseau 3 décembre 2021
0 commentaire 0 FacebookTwitterEmail

Laisser un commentaire Annuler la réponse

Enregistrer mon nom, courriel, et site web pour la prochaine fois que je vais commenter.

À PROPOS

Physiotek a développé une expertise dans le traitement des céphalées et des douleurs au niveau de la tête et du visage. Cela nécessite une grande maîtrise de l'articulation temporo-mandibulaire, de la région cervicale, et beaucoup, BEAUCOUP plus ! La Clinique de la Tête a ainsi comme objectif d'être une référence à la fois pour les patients ET les professionnels de la santé.

Dernières nouvelles

  • Un nouveau site web

    6 février 2020
  • Physiotek s’implique dans la formation continue

    23 février 2019
  • Physiotek a complété la formation CRAFTA

    25 mai 2018

Derniers blogues

  • Douleur et hyperventilation

    19 novembre 2022
  • Quel est le lien entre le CGRP et la migraine ?

    17 octobre 2021
  • L’impact de la posture de sommeil et des oreillers sur les céphalées et cervicalgies matinales

    30 août 2021
  • Pourquoi l’implication de la posture serait plus prévalente chez les sujets avec céphalée de tension ?

    18 février 2021
  • Migraine vestibulaire et physiothérapie

    31 janvier 2021

Dernières publications

  • Cervical musculoskeletal and sensorimotor impairments 4 weeks to 6 months following mild traumatic brain injury: An observational cohort study

    20 novembre 2022
  • Head/neck pain characteristics after spontaneous cervical artery dissection in the acute phase and on a long-run

    19 novembre 2022
  • The Link between Pediatric Obstructive Sleep Apnea and Attention Deficit Hyperactivity Disorder

    16 juin 2022
  • Lower spinal postural variability during laptop-work in subjects with cervicogenic headache compared to healthy controls

    16 octobre 2021
  • Is the headache in patients with vestibular migraine attenuated by vestibular rehabilitation?

    16 octobre 2021

Ordre professionnel

Citation

Le secret pour avoir la santé est que le corps soit agité et que l’esprit se repose.

- Vincent Voiture

TAGS

alimentation anticorps anti-CGRP apnée du sommeil aura AVC cervical CGRP chiropratique coliques commotion cérébrale céphalée cervicogénique céphalée de tension céphalée médicamenteuse céphalée post-traumatique céphalées dentisterie douleur douleur chronique décès développement enfance génétique imagerie inflammation manipulation manipulation vertébrale migraine médication neurodynamique nutrition occlusion physiothérapie posture produits naturels psychologie respiration rééducation vestibulaire sommeil stress traitement troubles du sommeil vulgarisation étourdissements étourdissements cervicogéniques évaluation
  • Facebook
  • Twitter
  • Email
Footer Logo

Tous droits réservés © Physiotek 2020

La Clinique de la Tête
  • Accueil
  • SERViCES
    • Céphalées
    • Mâchoire
    • Cervicalgie
  • Corpus
    • 1. Introduction
    • 2. Généralités
      • 2.1 Histoire
      • 2.2 Classification
      • 2.3 Épidémiologie
      • 2.4 Évaluation subjective
      • 2.5 Évaluation neurologique
      • 2.6 Évaluation vasculaire
      • 2.7 Étourdissements
      • 2.8 Formulaires
    • 3. Céphalée cervicogénique
      • 3.1 Description
        • 3.1.1 Classification
        • 3.1.2 Épidémiologie
        • 3.1.3 Pathophysiologie
        • 3.1.4 Facteurs contributifs
        • 3.1.5 Étourdissements cervicogéniques
        • 3.1.6 Références
      • 3.2 Évaluation
      • 3.3 Traitement
    • 4. Céphalée de tension
      • 4.1 Description
        • 4.1.1 Classification
        • 4.1.2 Épidémiologie
        • 4.1.3 Pathophysiologie
        • 4.1.4 Facteurs contributifs
        • 4.1.5 Diagnostic différentiel
        • 4.1.6 Références
      • 4.2 Évaluation
      • 4.3 Traitement
    • 5. Migraine
      • 5.1 Description
        • 5.1.1 Classification
        • 5.1.2 Les phases d’une crise
        • 5.1.3 Facteurs déclenchants
        • 5.1.4 Épidémiologie
        • 5.1.5 Pathophysiologie
        • 5.1.6 Composante génétique
        • 5.1.7 Composante pharmacologique
        • 5.1.8 Théorie du continuum
        • 5.1.9 Intérêt de la physiothérapie
        • 5.1.10 Conclusion
        • 5.1.11 Références
      • 5.2 Évaluation
      • 5.3 Traitement
      • 5.4 Particularités chez les femmes
      • 5.5 Particularités chez les enfants
    • 6. Céphalées trigémino-autonomiques
    • 7. Dysfonction temporo-mandibulaire
    • 8. Autres désordres
      • 8.5 Troubles du sommeil
        • 8.5.1 Le syndrome d’apnées du sommeil
        • 8.5.2 Autres troubles du sommeil
        • 8.5.3 Liens entre sommeil et douleur
        • 8.5.4 Liens entre sommeil et céphalées
        • 8.5.5 Réféfences
      • 8.7 Céphalée post-COVID
  • Blogue
    • DiVERS DOULEUR PATHOLOGiES RECHERCHE SANTÉ THÉRAPiES
      DiVERS

      Migraine World Summit 2020

      12 mars 2020

      DiVERS

      « Skull-Breaker Challenge » le défi TikTok hyper dangereux

      11 mars 2020

      DiVERS

      L’intelligence artificielle découvre un nouvel antibiotique

      27 février 2020

      DiVERS

      La position de la langue influence le développement…

      29 mai 2019

      DOULEUR

      Douleur et hyperventilation

      19 novembre 2022

      DOULEUR

      L’impact de la posture de sommeil et des…

      30 août 2021

      DOULEUR

      Nutrition et douleurs chroniques

      29 juillet 2020

      DOULEUR

      Radiculopathie cervicale ou traitement de canal ?

      27 avril 2020

      PATHOLOGiES

      Quel est le lien entre le CGRP et…

      17 octobre 2021

      PATHOLOGiES

      Pourquoi l’implication de la posture serait plus prévalente…

      18 février 2021

      PATHOLOGiES

      Tests pour étourdissements cervicogéniques

      18 octobre 2020

      PATHOLOGiES

      La céphalée attribuable à la tension artérielle

      30 juillet 2020

      RECHERCHE

      Le niveau de douleur adulte dicté par les…

      26 avril 2020

      RECHERCHE

      Dysfonction musculaire chez les migraineux

      24 décembre 2015

      RECHERCHE

      Quelles sont les tendances dans le monde des…

      9 mars 2015

      RECHERCHE

      Un lien entre migraine et coliques ?

      15 octobre 2014

      SANTÉ

      Le curcuma comme anti-inflammatoire ?

      28 février 2016

      SANTÉ

      Le sucre rend-t-il votre enfant hyperactif ?

      25 mars 2015

      SANTÉ

      Êtes-vous couche-tôt ou couche-tard ?

      13 mai 2014

      SANTÉ

      La génétique influence les effets du stress chronique

      6 novembre 2013

      THÉRAPiES

      Migraine vestibulaire et physiothérapie

      31 janvier 2021

      THÉRAPiES

      Les ostéopathes ne sont pas autorisés à pratiquer…

      4 janvier 2021

      THÉRAPiES

      La respiration abdominale comme thérapie ?

      4 janvier 2021

      THÉRAPiES

      La migraine et l’hygiène de vie

      12 juillet 2020

  • Info
    • FAQ
    • Ressources
    • Outils
    • Traitements
      • Médicaments
    • Commotion
  • Biblio
  • Exercices
  • Contact
Sign In

Me garder connecté

Oublié votre mot de passe ?

Password Recovery

A new password will be emailed to you.

Have received a new password? Se connecter ici